15-04-2008
Eurofins MWG Operon expands capacities with a second Genome Sequencer FLX system to address the growing sequencing demand

Eurofins MWG Operon, European market leader in genome sequencing and leading expert in next generation sequencing is further expanding its capacities in order to meet the demands of a steadily increasing number of sequencing customers across Europe.

02-12-2007
MWG and Operon are joining forces

Operon Biotechnologies, Eurofins MWG Operon and Eurofins Medigenomix - all part of the Eurofins Genomics network - announced today that they have agreed to work together in order to create a new worldwide leader in the competitive custom oligonucleotide market.

18-07-2007
Eurofins MWG Operon / Eurofins Medigenomix develop new software to optimise sequences for gene synthesis

Eurofins MWG Operon / Eurofins Medigenomix develop GENEius software with unique features for gene synthesis.

12-07-2007
Eurofins MWG Operon / Eurofins Medigenomix upgrade to a Genome Sequencer FLX for sequencing services

Eurofins MWG Operon AG/ Eurofins Medigenomix GmbH have successfully upgraded their Genome Sequencer 20 from Roche to the next generation Genome Sequencer FLX system.

24-05-2007
 Eurofins Medigenomix / Eurofins MWG Operon sequence Wacker Chemie AG.s bacterial protein production strain

Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between WACKER’s proprietary industrial protein production E. coli strain and its corresponding parental strain.